Doctor profile · Federal record
Dr. Yunhui Hsiang, M.D., PHD
Medical Oncology Physician (CMS: Hematology/Oncology) · Ft Walton Beach, FL
- NPI 1457390353
- Accepts Medicare
- MIPS 97.9 / 100 · 2023
- 39 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1024 Mar Walt Dr
Ft Walton Beach, FL 325476645
(850) 863-3148
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- February 10, 2012
- Year of graduation
- 1987 — 39 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Florida #ME81495
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1457390353. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
338,842
Distinct HCPCS
10
Medicare allowed
$4,572,164
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 88,500 | 52 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 39,600 | 26 | $52 | |
Q5125 |
Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | 35,280 | 16 | $1 | |
Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 32,760 | 15 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 31,740 | 162 | $23 | |
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 17,850 | 18 | $0 | |
J1453 |
Injection, fosaprepitant, 1 mg | 13,650 | 14 | $0 | |
J9311 |
Injection, rituximab 10 mg and hyaluronidase | 11,340 | 18 | $37 | |
J9041 |
Injection, bortezomib, 0.1 mg | 9,990 | 11 | $5 | |
J9267 |
Injection, paclitaxel, 1 mg | 8,926 | 12 | $0 |
In context: peer comparison
Among 1 peers in Ft Walton Beach Medical Oncology Physician, average services per provider: 6,516. This provider delivers 52× the peer median.Open Payments
Industry payments received
All-time total
$3,525
Transactions
135
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 21 | $369.42 | |
| Regeneron Healthcare Solutions, INC. | 13 | $360.27 | |
| Celgene Corporation | 16 | $331.04 | |
| Janssen Biotech, INC. | 14 | $245.08 | |
| Genzyme Corporation | 9 | $200.31 | |
| Lilly USA, LLC | 10 | $175.11 | |
| Merck Sharp & Dohme LLC | 7 | $155.31 | |
| AstraZeneca Pharmaceuticals Lp | 8 | $146.20 | |
| Abbvie INC. | 7 | $132.55 | |
| Genentech USA, INC. | 6 | $112.65 | |
| Pfizer INC. | 7 | $101.40 | |
| Daiichi Sankyo INC. | 5 | $96.10 | |
| E.R. Squibb & Sons, L.L.C. | 5 | $90.81 | |
| Blueprint Medicines Corporation | 4 | $83.63 | |
| Takeda Pharmaceuticals U.S.A., INC. | 3 | $77.34 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
535
Patients
152
Total drug cost
$405,730
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 86 | 23 | $2,052 |
| Ondansetron Hcl | Generic | 83 | 42 | $1,043 |
| Prochlorperazine Maleate | Generic | 52 | 33 | $679 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 45 | 14 | $982 |
| Gabapentin | Generic | 38 | 11 | $485 |
| Anastrozole | Generic | 31 | 0 | $946 |
| Oxycodone Hcl | Generic | 28 | 0 | $226 |
| Lidocaine-Prilocaine (Lidocaine/Prilocaine) | Brand | 26 | 13 | $452 |
| Hydroxyurea | Generic | 25 | 0 | $1,267 |
| Calquence (Acalabrutinib Maleate) | Brand | 24 | 0 | $383,799 |
Hospital affiliations
Frequently asked questions
What is Dr. Yunhui Hsiang's medical specialty?
Dr. Yunhui Hsiang practices Medical Oncology Physician in Ft Walton Beach, FL.
Where does Dr. Yunhui Hsiang practice?
Dr. Yunhui Hsiang practices at 1024 Mar Walt Dr, Ft Walton Beach, FL 325476645. Office phone: 8508633148.
What is Dr. Yunhui Hsiang's NPI?
Dr. Yunhui Hsiang's National Provider Identifier (NPI) is 1457390353, issued by NPPES.
Does Dr. Yunhui Hsiang accept Medicare assignment?
Yes. Dr. Yunhui Hsiang accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Yunhui Hsiang commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram (HCPCS Q5125). Source: CMS Medicare Physician & Other Practitioners file.